Synergy Promise Meets Dilution — Can Marvell Rebuild Trust?
Marvell plunged 12.72% Monday after announcing an all-stock Lumentum acquisition, putting dilution and execution risk in focus. Each Lumentum share converts into 4.5 Marvell shares, implying ~$115B enterprise value; Marvell holders would own ~67%, with over $1B in annualized synergies targeted. Closing is expected in H1 2028. Bulls see a complete AI optical-interconnect platform; bears cite dilution, regulatory, and timing risks. What will decide a re-rating: financing discipline, synergy delivery, or customer retention?